simplified_fnas v.0
An assessment score used to evaluate the severity of opioid abstinence syndrome in newborns.
Use to calculate the score for the Simplified Finnegan Neonatal Abstinence Scoring Tool (sFNAS). The sFNAS is a simplified 10-item version of the original 21-item Finnegan Neonatal Abstinence Scoring Tool (FNAS). The parameters evaluate central nervous system, autonomic and gastrointestinal signs of neonatal abstinence syndrome (NAS). The sFNAS score is designed to be compared overtime through continuous monitoring every 3 to 4 hours. The recommendation to start pharmacological treatment is given if the following is registered: - Three consecutive scores of 6 or greater, - Two consecutive scores of 10 or greater.
Use only in neonatal patients when there is maternal drug abuse as shown by history or toxicology. Use to measure and analyse the presence of signs every 3 to 4 hours.
Not to be used in neonatal patients without maternal drug abuse.
Gomez Pomar E, Finnegan LP, Devlin L, Bada H, Concina VA, Ibonia KT, Westgate PM. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA. BMJ Open. 2017 Sep 27;7(9):e016176. doi: 10.1136/bmjopen-2017-016176. PMID: 28963285; PMCID: PMC5623549. Mangat AK, Schmölzer GM, Kraft WK. Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). Semin Fetal Neonatal Med. 2019 Apr;24(2):133-141. doi: 10.1016/j.siny.2019.01.009. Epub 2019 Feb 5. PMID: 30745219; PMCID: PMC6451887.
openEHR-EHR-OBSERVATION.simplified_finnegan_neonatal_abstinence_score, openEHR-EHR-EVALUATION.recommendation
